KLC
TMCI icon

Kent Lake Capital’s Treace Medical Concepts TMCI Stock Holding History

Kent Lake Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$4.99M Buy
+750,000
New +$6.06M 2.25% 20

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kent Lake Capital's TMCI Position: Q2 2024 in Review

Kent Lake Capital opened a new position in Treace Medical Concepts (TMCI) in Q2 2024: 750,000 shares worth $4.99M. The stake represents 2.25% of the portfolio and ranks #20 among its holdings.

128 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • Kent Lake Capital held 750,000 shares of Treace Medical Concepts worth $4.99M as of Q2 2024.
  • Treace Medical Concepts was a new Kent Lake Capital position in Q2 2024.
  • Treace Medical Concepts made up 2.25% of Kent Lake Capital's portfolio in Q2 2024, its #20 holding.
  • 128 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Kent Lake Capital's 13F filing for Q2 2024, filed 14 Aug 2024.